Fresenius Medical Care AG (FMS) Common Equity: 2009-2024
Historic Common Equity for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $16.3 billion.
- Fresenius Medical Care AG's Common Equity rose 9.84% to $16.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 billion, marking a year-over-year increase of 9.84%. This contributed to the annual value of $17.1 billion for FY2024, which is 698.58% up from last year.
- As of Q3 2025, Fresenius Medical Care AG's Common Equity stood at $16.3 billion, which was up 9.84% from $16.2 billion recorded in Q2 2025.
- Fresenius Medical Care AG's Common Equity's 5-year high stood at $16.9 billion during Q3 2022, with a 5-year trough of $15.4 billion in Q2 2021.
- In the last 5 years, Fresenius Medical Care AG's Common Equity had a median value of $16.3 billion in 2025 and averaged $16.2 billion.
- As far as peak fluctuations go, Fresenius Medical Care AG's Common Equity skyrocketed by 876.8% in 2021, and later crashed by 332.24% in 2024.
- Over the past 5 years, Fresenius Medical Care AG's Common Equity (Quarter) stood at $16.0 billion in 2021, then decreased by 1.44% to $15.8 billion in 2022, then rose by 1.21% to $16.0 billion in 2023, then rose by 5.63% to $16.9 billion in 2024, then decreased by 3.5% to $16.3 billion in 2025.
- Its last three reported values are $16.3 billion in Q3 2025, $16.2 billion for Q2 2025, and $16.3 billion during Q1 2025.